These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 1510457)
1. Stability of meropenem and effect of 1 beta-methyl substitution on its stability in the presence of renal dehydropeptidase I. Fukasawa M; Sumita Y; Harabe ET; Tanio T; Nouda H; Kohzuki T; Okuda T; Matsumura H; Sunagawa M Antimicrob Agents Chemother; 1992 Jul; 36(7):1577-9. PubMed ID: 1510457 [TBL] [Abstract][Full Text] [Related]
2. Inactivation of new carbapenem antibiotics by dehydropeptidase-I from porcine and human renal cortex. Hikida M; Kawashima K; Yoshida M; Mitsuhashi S J Antimicrob Chemother; 1992 Aug; 30(2):129-34. PubMed ID: 1301069 [TBL] [Abstract][Full Text] [Related]
3. Laboratory data which differentiate meropenem and imipenem. Edwards JR; Turner PJ Scand J Infect Dis Suppl; 1995; 96():5-10. PubMed ID: 7652504 [TBL] [Abstract][Full Text] [Related]
4. [Preclinical evaluation of meropenem, a new parenteral carbapenem]. Edwards JR New Microbiol; 1995 Oct; 18 Suppl():19S-31S. PubMed ID: 8574929 [TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of dehydropeptidase-I and comparative in vitro and in vivo stabilities of PS-5 derivatives modified at the C-3 side chain. Sakamoto M; Yamamoto K; Isshiki K; Tone H; Ishikura T; Fukagawa Y; Yoshioka T Chem Pharm Bull (Tokyo); 1991 Feb; 39(2):341-8. PubMed ID: 2054858 [TBL] [Abstract][Full Text] [Related]
6. Biochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability properties. Yang Y; Testa RT; Bhachech N; Rasmussen BA; Bush K Antimicrob Agents Chemother; 1999 Dec; 43(12):2904-9. PubMed ID: 10582880 [TBL] [Abstract][Full Text] [Related]
7. Stability of new carbapenem DA-1131 to renal dipeptidase (dehydropeptidase I). Park SW; We JS; Kim GW; Choi SH; Park HS Antimicrob Agents Chemother; 2002 Feb; 46(2):575-7. PubMed ID: 11796382 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity of a new carbapenem antibiotic, BO-2727, with potent antipseudomonal activity. Nakagawa S; Hashizume T; Matsuda K; Sanada M; Okamoto O; Fukatsu H; Tanaka N Antimicrob Agents Chemother; 1993 Dec; 37(12):2756-9. PubMed ID: 8109950 [TBL] [Abstract][Full Text] [Related]
10. Renal dehydropeptidase-I stability of LJC 10,627, a new carbapenem antibiotic. Hikida M; Kawashima K; Nishiki K; Furukawa Y; Nishizawa K; Saito I; Kuwao S Antimicrob Agents Chemother; 1992 Feb; 36(2):481-3. PubMed ID: 1605616 [TBL] [Abstract][Full Text] [Related]
11. Even apparently insignificant chemical deviations among bioequivalent generic antibiotics can lead to therapeutic nonequivalence: the case of meropenem. Agudelo M; Rodriguez CA; Pelaez CA; Vesga O Antimicrob Agents Chemother; 2014; 58(2):1005-18. PubMed ID: 24277034 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity of 1beta-methyl-2-[5'-isoxazoloethenylpyrrolidin-3'-ylthio]carbapenems. Kim DJ; Seo KJ; Lee KS; Shin KJ; Yoo KH; Kim DC; Park SW Bioorg Med Chem Lett; 2000 Dec; 10(24):2799-802. PubMed ID: 11133095 [TBL] [Abstract][Full Text] [Related]
13. Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase. Kropp H; Sundelof JG; Hajdu R; Kahan FM Antimicrob Agents Chemother; 1982 Jul; 22(1):62-70. PubMed ID: 7125632 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of meropenem in animals, healthy volunteers, and patients. Moon YS; Chung KC; Gill MA Clin Infect Dis; 1997 Feb; 24 Suppl 2():S249-55. PubMed ID: 9126700 [TBL] [Abstract][Full Text] [Related]
15. In-vitro and in-vivo antibacterial activity of imipenem against clinical isolates of bacteria. Mitsuhashi S J Antimicrob Chemother; 1983 Dec; 12 Suppl D():53-64. PubMed ID: 6607914 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I. Ubukata K; Hikida M; Yoshida M; Nishiki K; Furukawa Y; Tashiro K; Konno M; Mitsuhashi S Antimicrob Agents Chemother; 1990 Jun; 34(6):994-1000. PubMed ID: 2203313 [TBL] [Abstract][Full Text] [Related]
18. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase. Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301 [TBL] [Abstract][Full Text] [Related]
19. Heteroaryliumthio substituted carbapenem derivatives: synthesis and in vitro activity of 1 beta-methyl-2-(dihydropyrrolotriazoliumthio)carbapenems. Wildonger KJ; Ratcliffe RW J Antibiot (Tokyo); 1993 Dec; 46(12):1866-82. PubMed ID: 8294246 [TBL] [Abstract][Full Text] [Related]
20. CP0569, a new broad-spectrum injectable carbapenem. Part 1: synthesis and structure-activity relationships. Aihara K; Kano Y; Shiokawa S; Sasaki T; Setsu F; Sambongi Y; Ishii M; Tohyama K; Ida T; Tamura A; Atsumi K; Iwamatsu K Bioorg Med Chem; 2003 Aug; 11(16):3475-85. PubMed ID: 12878141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]